Immucor acquires Sirona Genomics - MarketLine Financial Deals

Immucor acquires Sirona Genomics

Immucor acquires Sirona Genomics - MarketLine Financial Deals
Immucor acquires Sirona Genomics
Published Mar 04, 2016
2 pages — Published Mar 04, 2016
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Immucor, Inc., a provider of transfusion and transplantation diagnostic products, has acquired Sirona Genomics. Both the companies are based in the US.

  
Source:
Document ID
MA165060_160309
Country
Ticker
BLUD=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Immucor acquires Sirona Genomics" Mar 04, 2016. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Immucor-acquires-Sirona-Genomics-2052-118440>
  
APA:
MarketLine Financial Deals. (2016). Immucor acquires Sirona Genomics Mar 04, 2016. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Immucor-acquires-Sirona-Genomics-2052-118440>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.